Traditional processes used to discover new materials are complex, time-consuming, and costly, often requiring years of sustained effort. Recent advances in large language models (LLMs) have ...
Collaboration with AstraZeneca will focus on scaling cell therapy manufacturing using GMP-ready end-to-end robotic biomanufacturing technology SAN FRANCISCO--(BUSINESS WIRE)--#AstraZeneca--Multiply ...
The collaboration will focus on end-to-end robotic automation of industry-standard instruments used in cell therapy production sing Multiply Labs' robotic biomanufacturing system. The goal is to ...
Multiply Labs Inc. today announced an agreement with AstraZeneca to evaluate the potential for applying good manufacturing practice, or GMP-ready, robotic systems to commercial-scale cell therapy ...
Multiply Labs, a developer of autonomous manufacturing technology for advanced therapies, entered an agreement with AstraZeneca to evaluate the potential for applying GMP (Good Manufacturing Practices ...
A competition calling for research projects involving so-called AI scientists shows just how fast this technology is moving. A number of startups and university teams that are building “AI scientists” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results